Sorrento Therapeutics, Inc. Stock
Stocks
SRNE
US83587F2020
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000700 USD | -53.33% |
|
+16.67% | -73.08% |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces CEO Changes, Effective March 13, 2026 | CI |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 67.15M 58.73M 54.18M 50.04M 94.94M 6.4B 96.54M 647M 254M 3.15B 252M 247M 10.85B | P/E 2021 |
-3.2x | P/E 2022 | -0.65x |
|---|---|---|---|---|---|
| Enterprise Value | 152M 133M 122M 113M 214M 14.47B 218M 1.46B 574M 7.13B 569M 557M 24.5B | EV / Sales 2021 |
29.1x | EV / Sales 2022 | 7.89x |
| Free-Float |
98.65% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -53.33% | ||
| 1 week | +16.67% | ||
| Current month | +16.67% | ||
| 1 month | -53.33% | ||
| 3 months | -69.57% | ||
| 6 months | -77.42% | ||
| Current year | -73.08% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.1 |
| 3 years | 0 | | 0.42 |
| 5 years | 0 | | 9.63 |
| 10 years | 0 | | 19.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 61 | 2011-03-31 |
Scott Schaus
CTO | Chief Tech/Sci/R&D Officer | - | 2022-02-28 |
John Waldheim
LAW | General Counsel | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Henry Ji
CHM | Chairman | 61 | 2017-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -53.33% | +16.67% | -70.83% | -99.80% | 381K | |
| +1.84% | -0.66% | +59.82% | +92.96% | 54.88B | |
| -4.14% | -8.06% | +58.96% | +118.67% | 54.63B | |
| -2.24% | +3.59% | +17.75% | +477.47% | 25.06B | |
| -1.60% | -6.21% | -18.96% | -15.21% | 23.14B | |
| +2.43% | +1.06% | +42.44% | -1.27% | 19.87B | |
| -3.19% | 0.00% | +35.60% | -26.98% | 17.55B | |
| -6.84% | +2.18% | +195.12% | +357.18% | 16.5B | |
| +8.74% | +3.51% | +51.91% | +726.40% | 15.75B | |
| -1.05% | +1.16% | +25.95% | +194.27% | 14.2B | |
| Average | -5.94% | -0.25% | +39.78% | +182.37% | 24.16B | |
| Weighted average by Cap. | -0.90% | -1.45% | +51.26% | +177.14% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 52.9M 46.28M 42.68M 39.42M 74.8M 5.05B 76.06M 510M 200M 2.49B 199M 194M 8.55B | 62.84M 54.97M 50.7M 46.83M 88.85M 5.99B 90.34M 606M 238M 2.95B 236M 231M 10.15B |
| Net income | -428M -375M -346M -319M -606M -40.85B -616M -4.13B -1.62B -20.12B -1.61B -1.57B -69.18B | -573M -501M -462M -427M -810M -54.63B -824M -5.52B -2.17B -26.91B -2.15B -2.1B -92.53B |
| Net Debt | 111M 96.82M 89.31M 82.49M 157M 10.56B 159M 1.07B 419M 5.2B 416M 407M 17.88B | 84.53M 73.93M 68.2M 62.99M 120M 8.06B 122M 815M 320M 3.97B 317M 310M 13.65B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | US$0.000700 | -53.33% | 749,540 |
| 26-07-09 | US$0.001500 | +36.36% | 37,196 |
| 26-07-08 | US$0.001100 | -15.38% | 334,705 |
| 26-07-07 | US$0.001300 | +85.71% | 27,846 |
| 26-07-06 | US$0.000700 | +27.27% | 1,083,909 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SRNE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
